Literature DB >> 33717412

Gait parameters as tools for analyzing phenotypic alterations of a mouse model of Charcot-Marie-Tooth disease.

Sun Hee Hwang1, Eun Hyuk Chang2, Geon Kwak3, Hyeonjin Jeon4,5, Byung-Ok Choi1,3, Young Bin Hong4,5.   

Abstract

Charcot-Marie-Tooth disease (CMT), a genetically heterogeneous group of diseases in the peripheral nervous system, is characterized by progressive and symmetrical distal weakness resulting in gait abnormality. The necessity of the diagnostic and prognostic biomarkers has been raised for both basic research and clinical practice in CMT. Since biomarkers for animal study of CMT are limited, we evaluated the feasibility of gait parameters as tool for measuring disease phenotype of CMT mouse model. Using a Trembler-J (Tr-J) mouse, a CMT type 1 (CMT1) mouse model, we analyzed kinematic parameters such as angles of hip, knee and ankle (sagittal plane), and spatial parameters including step width and stride length (transverse plane). Regarding of kinematic parameters, Tr-J mice exhibited less plantarflexed ankle during the swing phase and more dorsiflexed ankle at the terminal stance compared to control mice. The range of motion in ankle angle of Tr-J mice was significantly greater than that of control mice. In spatial parameter, Tr-J mice exhibited wider step width compared to control mice. These results are similar to previously reported gait patterns of CMT1 patients. In comparison with other markers such as nerve conduction study and rotarod test, gait parameters dynamically reflected the disease progression of CMT1 mice. Therefore, these data imply that gait parameters can be used as useful tools to analyzed the disease phenotype and progression during preclinical study of peripheral neuropathy such as CMT.
© 2021 The Author(s). Published by Informa UK Limited, trading as Taylor & Francis Group.

Entities:  

Keywords:  Biomarker; Charcot-Marie-Tooth disease; gait analysis; mouse model

Year:  2021        PMID: 33717412      PMCID: PMC7935128          DOI: 10.1080/19768354.2021.1880967

Source DB:  PubMed          Journal:  Anim Cells Syst (Seoul)        ISSN: 1976-8354            Impact factor:   1.815


  18 in total

1.  The characteristics of gait in Charcot-Marie-Tooth disease types I and II.

Authors:  Christopher John Newman; Michael Walsh; Rory O'Sullivan; Ann Jenkinson; Damien Bennett; Bryan Lynch; Timothy O'Brien
Journal:  Gait Posture       Date:  2006-09-28       Impact factor: 2.840

2.  Genetic aspects of hereditary motor and sensory neuropathy (types I and II).

Authors:  A E Harding; P K Thomas
Journal:  J Med Genet       Date:  1980-10       Impact factor: 6.318

3.  High-dosage ascorbic acid treatment in Charcot-Marie-Tooth disease type 1A: results of a randomized, double-masked, controlled trial.

Authors:  Richard A Lewis; Michael P McDermott; David N Herrmann; Ahmet Hoke; Lora L Clawson; Carly Siskind; Shawna M E Feely; Lindsey J Miller; Richard J Barohn; Patricia Smith; Elizabeth Luebbe; Xingyao Wu; Michael E Shy
Journal:  JAMA Neurol       Date:  2013-08       Impact factor: 18.302

4.  Oral high dose ascorbic acid treatment for one year in young CMT1A patients: a randomised, double-blind, placebo-controlled phase II trial.

Authors:  Camiel Verhamme; Rob J de Haan; Marinus Vermeulen; Frank Baas; Marianne de Visser; Ivo N van Schaik
Journal:  BMC Med       Date:  2009-11-12       Impact factor: 8.775

5.  The natural history of Charcot-Marie-Tooth type 1A in adults: a 5-year follow-up study.

Authors:  Camiel Verhamme; Ivo N van Schaik; Johannes H T M Koelman; Rob J de Haan; Marianne de Visser
Journal:  Brain       Date:  2009-12       Impact factor: 13.501

6.  Effect of ascorbic acid in patients with Charcot-Marie-Tooth disease type 1A: a multicentre, randomised, double-blind, placebo-controlled trial.

Authors:  Joëlle Micallef; Shahram Attarian; Odile Dubourg; Pierre-Marie Gonnaud; Jean-Yves Hogrel; Tanya Stojkovic; Rafaelle Bernard; Elisabeth Jouve; Severine Pitel; Francois Vacherot; Jean-Francois Remec; Laurent Jomir; Eric Azabou; Mahmoud Al-Moussawi; Marie-Noelle Lefebvre; Laurence Attolini; Sadek Yaici; Daniel Tanesse; Michel Fontes; Jean Pouget; Olivier Blin
Journal:  Lancet Neurol       Date:  2009-10-07       Impact factor: 44.182

7.  Different clinical and magnetic resonance imaging features between Charcot-Marie-Tooth disease type 1A and 2A.

Authors:  K W Chung; B C Suh; M E Shy; S Y Cho; J H Yoo; S W Park; H Moon; K D Park; K G Choi; S Kim; S B Kim; D S Shim; S M Kim; I N Sunwoo; B O Choi
Journal:  Neuromuscul Disord       Date:  2008-07-07       Impact factor: 4.296

8.  Comparison of Trembler and Trembler-J mouse phenotypes: varying severity of peripheral hypomyelination.

Authors:  E W Henry; J S Cowen; R L Sidman
Journal:  J Neuropathol Exp Neurol       Date:  1983-11       Impact factor: 3.685

9.  An exploratory randomised double-blind and placebo-controlled phase 2 study of a combination of baclofen, naltrexone and sorbitol (PXT3003) in patients with Charcot-Marie-Tooth disease type 1A.

Authors:  Shahram Attarian; Jean-Michel Vallat; Laurent Magy; Benoît Funalot; Pierre-Marie Gonnaud; Arnaud Lacour; Yann Péréon; Odile Dubourg; Jean Pouget; Joëlle Micallef; Jérôme Franques; Marie-Noëlle Lefebvre; Karima Ghorab; Mahmoud Al-Moussawi; Vincent Tiffreau; Marguerite Preudhomme; Armelle Magot; Laurène Leclair-Visonneau; Tanya Stojkovic; Laura Bossi; Philippe Lehert; Walter Gilbert; Viviane Bertrand; Jonas Mandel; Aude Milet; Rodolphe Hajj; Lamia Boudiaf; Catherine Scart-Grès; Serguei Nabirotchkin; Mickael Guedj; Ilya Chumakov; Daniel Cohen
Journal:  Orphanet J Rare Dis       Date:  2014-12-18       Impact factor: 4.123

10.  Overexpression of mutant HSP27 causes axonal neuropathy in mice.

Authors:  Jinho Lee; Sung-Chul Jung; Jaesoon Joo; Yu-Ri Choi; Hyo Won Moon; Geon Kwak; Ha Kyung Yeo; Ji-Su Lee; Hye-Jee Ahn; Namhee Jung; Sunhee Hwang; Jingeun Rheey; So-Youn Woo; Ji Yon Kim; Young Bin Hong; Byung-Ok Choi
Journal:  J Biomed Sci       Date:  2015-06-19       Impact factor: 8.410

View more
  1 in total

1.  Farnesol Ameliorates Demyelinating Phenotype in a Cellular and Animal Model of Charcot-Marie-Tooth Disease Type 1A.

Authors:  Na-Young Park; Geon Kwak; Hyun-Myung Doo; Hye-Jin Kim; So-Young Jang; Yun-Il Lee; Byung-Ok Choi; Young-Bin Hong
Journal:  Curr Issues Mol Biol       Date:  2021-11-13       Impact factor: 2.976

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.